Article
Pharmacy Times publishes a new journal for the growing specialty pharmacy market with prestigious editorial board and industry leaders.
FOR IMMEDIATE RELEASE
Contact: Bill Schu, Group Editorial Director, (609) 716-7777, bschu@mdng.com
Pharmacy Times Launches New Journal on Specialty PharmacyPharmacy Timespublishes a new journal for the growing specialty pharmacy market with prestigious editorial board and industry leaders.
PLAINSBORO, NJ (November 2, 2010)—Pharmacists serving the growing field of specialty pharmacy now have a new resource from the leading pharmacy publication. Pharmacy Times has launched a quarterly publication focused on the key areas surrounding specialty pharmaceuticals and the enhanced practice needs of pharmacists and other key personnel in this field. The inaugural issue of Specialty Pharmacy Times brings together insights from leading voices in the specialty pharmaceuticals industry, and introduces Dan Steiber, RPh, Principal of D2 Pharma Consulting LLC, as the new Editor-in-Chief.
In the cover article, David M. Suchanek, RPh, discusses Fair Market Value (FMV)—an issue that is “one of the hottest topics in the industry,” according to the author. The article offers an in-depth analysis of FMV, including Obama administration regulatory mechanisms and their impact on the commercial marketplace. In his feature article, “What Will Drive the Specialty Pharmacy Models of Tomorrow?” editorial board member Randell J. Correia, PharmD, looks to the future of specialty pharmacy with a focus on chronic disease. “There’s a tsunami of specialty pharmaceuticals headed our way,” wrote Dr. Correia, Senior Vice President of Mail Service and Specialty Pharmacy at Prescription Solutions.
The Fall 2010 issue of Specialty Pharmacy Times also introduces a roster of regular contributors who are well-regarded in the field. In the first Washington Insights column, contributor Jayson Slotnik, JD, unravels key elements of the Affordable Care Act that define Average Manufacturer Price. A former Director of Medicare Reimbursement and Economic Policy at the Biotechnology Industry Organization in Washington, DC, Slotnik provides a true insider’s perspective.
“We are thrilled to include many important industry thought leaders in our journal, which will be the leader in peer-written articles covering significant aspects of the industry,” said Tighe Blazier, President of Pharmacy Times. “We’ve welcomed experts on REMS, new product pipelines, and current trends with this first issue, and we are focused 100% on the business and practice of specialty pharmacy.”
Specialty Pharmacy Times fills a much needed niche for one of the fastest growing markets in pharmacy. “As a leader in health care publishing, Pharmacy Times is in the perfect position to launch an industry-specific journal such as Specialty Pharmacy Times, which is rich in content, insight, and scope,” said Mike Hennessy, President and CEO of MJH & Associates, the parent company of Pharmacy Times.
Pharmacists can subscribe to Specialty Pharmacy Times by going to www.SpecialtyPharmacyTimes.com and register for a free subscription. For more information on the first issue, also visit www.PharmacyTimes.com.
AboutPharmacy Times
Pharmacy Times is a clinically based, monthly journal providing practical information pharmacists can use in their everyday practice. Each issue contains articles and features covering medication errors, drug interactions, patient education, pharmacy technology, disease state management, patient counseling, product news, pharmacy law, and specialty pharmacy. Pharmacy Times is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of free continuing pharmacy education.
Pharmacy Times is published by Intellisphere, LLC, a leading provider of health care publishing, research, information, and education. Operating within both traditional and digital media channels, Intellisphere serves the needs of health care professionals through an extensive suite of magazines, journals, e-mail databases, Web sites, events, and personal meetings.
Intellisphere reaches more than half a million health care professionals through Pharmacy Times, The American Journal of Managed Care, The American Journal of Pharmacy Benefits, MDNG, HCPlive.com, Oncology & Biotech News, Oncology Net Guide, Contemporary Oncology, andOncology Net Guide: Nurses’ Edition.